Hypertension Clinical Trial
To examine the role of isolated systolic hypertension and other predictors of all-cause and coronary heart disease mortality in elderly Blacks and whites of the Charleston Heart Study cohort of 1960 and to compare and pool those findings with the Evans County Heart Study findings in order to develop a logistic risk function for Blacks. Also, to identify predictors of physical functioning in older Blacks and whites and to prepare rosters of the off-spring of the Charleston cohort for future studies of genetic/familial influences on cardiovascular disease.
BACKGROUND:
Coronary heart disease is the leading cause of death among United States Blacks, where
coronary heart disease mortality rates are among the highest in the world. There has been a
marked decline in coronary heart disease mortality among Blacks in the United States
including South Carolina since 1968 for reasons not well explained, although hypertension
control probably has contributed to the decline. In spite of this decline, evidence emerged
that fatal and non-fatal coronary heart disease rates in Blacks exceeds those of whites.
Charleston Heart Study data showed that coronary heart disease cumulative survival
probabilities for Black men were lower than white men during the first 20 years of the 25
year observation period. A secular trend manifested itself with relatively higher rates in
Blacks but in any event, there was evidence that coronary disease was a major threat to
Blacks.
The Charleston Heart Study was initiated in 1960. Randomly selected Black and white men and
women 35 years of age and over were examined to obtain details concerning angina, myocardial
infarction, hypertension, smoking, blood pressure, height, weight, and serum cholesterol
levels. The total cohort was 2,283 persons. The last screening of the cohort was in
1974-1975 until the this study which started in 1984.
Over one half the Blacks in the United States live in the South and the Charleston Heart
Study offered the opportunity to study disease and disability status of elderly Blacks, in
an environment that included urban and rural residents.
DESIGN NARRATIVE:
In 1984-1985 a 25 year follow-up was conducted on the original Charleston Heart Study
cohort. The vital status of 98 percent of the 1960 cohort was ascertained. Ninety-three
percent of the survivors were revisited, interviewed, and measured for blood pressure,
weight, and height. The interaction of socioeconomic status, type A behavior and John Henry
behavior scores were tested. All-cause and coronary heart disease mortality were determined.
In 1987-1988 approximately 1,300 survivors were recalled for measurements of functional and
cognitive status using the Framingham Functional Disability Questionnaire so that
comparisons of results from Charleston and Framingham could be made. Measurements were made
of blood pressure, height, weight, and heart function by auscultation, ECG, and
echocardiography. Lipoproteins, glucose, and other biochemical parameters were assessed. The
biomedical and sociodemographic determinants of long-term survival in Black men and women
were quantified and compared with those of whites. The risk factor significance of
Minnesota-coded ECG abnormalities in Blacks versus whites were identified and quantified.
Familial aggregation of risk factors and potential causes of obesity were assessed.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |